Conus medullaris involvement in demyelinating disorders of the CNS: A comparative study

被引:11
|
作者
Etemadifar, Masoud [1 ,2 ]
Salari, Mehri [3 ]
Kargaran, Parisa K. [4 ]
Sigari, Amirhossein Akhavan [2 ]
Nouri, Hosein [2 ,5 ]
Etemadifar, Fatemeh [2 ]
Ebrahimi, Sara [2 ]
Sayahi, Newsha [2 ,6 ]
Sedaghat, Nahad [2 ,5 ]
机构
[1] Isfahan Univ Med Sci, Sch Med, Dept Neurosurg, Esfahan, Iran
[2] Isfahan Univ Med Sci, Alzahra Univ Hosp, Alzahra Res Inst, Esfahan, Iran
[3] Shahid Beheshti Univ Med Sci, Dept Neurol Dis, Tehran, Iran
[4] Mayo Clin, Ctr Regenerat Med, Dept Cardiovasc Med, Rochester, MN 55905 USA
[5] Universal Sci Educ & Res Network USERN, Network Immun Infect Malignancy & Autoimmun NIIMA, Esfahan, Iran
[6] Islamic Azad Univ, Fac Med, Dept Neurol, Esfahan, Iran
关键词
Demyelinating diseases; Neuromyelitis optica spectrum disorders; Multiple sclerosis; Myelin oligodendrocyte glycoprotein antibody; disorder; Conus medullaris; OLIGODENDROCYTE GLYCOPROTEIN MOG; MYELIN; CRITERIA; AQP4;
D O I
10.1016/j.msard.2021.103127
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Differentiation of the demyelinating disorders of the CNS seems challenging in practice. Conus medullaris, the cone-shaped end of the spinal cord, is more involved in anti-MOG patients based on preliminary studies, a possibly helpful detail in its differentiation. Nevertheless, the evidence is still limited and the underlying cause is unclear and undiscussed in previous studies. Objective: To contribute to preliminary studies by comparing conus involvement among patients with MS, antiAQP4, and anti-MOG diseases using larger sample size. Methods: More than a thousand MS, anti-AQP4, and anti-MOG patients were followed up for a maximum of five years, scanned for conus medullaris involvement. Data regarding each cohort were then analyzed and compared using statistical methods. Results: The rate of conus medullaris involvement was significantly higher in anti-MOG patietns (OR = 27.109, P < 0.001), followed by anti-AQP4 (OR = 4.944, P = 0.004), and MS patients (OR = reference). Survival analysis showed higher pace and cumulative incidence of conus attacks in anti-MOG patients. Conus-involved patients, showed no significant difference regarding age, sex, concurrent brain lesions, and their partial recovery. Predictive values show that the probability of being diagnosed with anti-MOG is roughly 13 times higher in conusinvolved patients (25.93% vs. 1.97%), although this probability was still higher for MS, as it has a much higher incidence. Conclusion: Despite minor differences, the results were in line with previous studies, confirming the higher rate of conus medullaris involvement among anti-MOG patients. Potential underlying causes are proposed and remain to be investigated in future studies.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Gestational age-specific reference standards of low-lying conus medullaris level in fetuses: a prospective cohort study
    Sun, Mengchun
    Chen, Mei
    Gao, Gan
    Tao, Benzhang
    Shang, Aijia
    CHILDS NERVOUS SYSTEM, 2023, 39 (04) : 997 - 1003
  • [32] Clinical relevance of conus medullaris and dural sac termination level with special reference to sacral hiatus apex: anatomical and MRI radiologic study
    Nasr, Ashraf Youssef
    ANATOMICAL SCIENCE INTERNATIONAL, 2017, 92 (04) : 456 - 467
  • [33] Clinical relevance of conus medullaris and dural sac termination level with special reference to sacral hiatus apex: anatomical and MRI radiologic study
    Ashraf Youssef Nasr
    Anatomical Science International, 2017, 92 : 456 - 467
  • [34] Variation of conus medullaris location based on magnetic resonance imaging of the lumbar spine in Indonesia: A study at Dr Soetomo General Academic Hospital, Surabaya, Indonesia
    Adhiatma, Aria
    Waloejo, Christrijogo Sumartono
    Wirabuana, Belindo
    Rahardjo, Eddy
    BALI MEDICAL JOURNAL, 2022, 11 (03) : 1839 - 1843
  • [35] Spinal cord involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a clinical and MRI study
    Ioannidis, Panagiotis
    Parissis, Dimitris
    Karapanayiotides, Theodoros
    Maiovis, Pantelis
    Karacostas, Dimitris
    Grigoriadis, Nikolaos
    ACTA NEUROLOGICA BELGICA, 2015, 115 (02) : 141 - 145
  • [36] COVID-19 infection and vaccination against COVID-19: Impact on managing demyelinating CNS disorders in Southern India- experience from a demyelinating disease registry
    Pandit, L.
    Sudhir, A.
    Malli, C.
    D'Cunha, A.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 66
  • [37] Clinical characteristics and outcomes of patients with Guillain-Barre and acquired CNS demyelinating overlap syndrome: a cohort study based on a literature review
    Mao, Zhifeng
    Hu, Xueqiang
    NEUROLOGICAL RESEARCH, 2014, 36 (12) : 1106 - 1113
  • [38] Role of optical coherence tomography in determining specific diagnostic pattern of retinal nerve fiber layer involvement in various central nervous system demyelinating diseases: An observational study
    Khandelwal, Dinesh
    Dadarwal, Kishor
    Hiremath, Ashwini
    Mathur, Vaibhav
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2021, 9 (05): : 376 - 380
  • [39] Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments
    Money, Kelli M.
    Baber, Ursela
    Saart, Emma
    Samaan, Soleil
    Sloane, Jacob A.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [40] Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders
    Panah, Mohammad Yazdan
    Vaheb, Saeed
    Mokary, Yousef
    Afshari-Safavi, Alireza
    Shaygannejad, Aysa
    Ebrahimi, Narges
    Shaygannejad, Vahid
    Mirmosayyeb, Omid
    VACCINE, 2024, 42 (23)